A group of researchers at Guelph University have created a vaccine that is supposed to target the intestinal flora of children who suffer from autism. Apparently such bacteria are common in children who suffer from the syndrome, and controlling the bacteria could control the symptoms.
The news is quite astounding, especially in consideration that there has never been official confirmation from the medical field of the actual cause of the syndrome. Some have long suspected other vaccines, which has been so far apparently debunked. Some others have found a link, which has been validated in trials, of the incidence of autism in the presence of contamination with certain pesticides, especially ones used in households.
This discovery however, points to the fact that the medical community at large might know more about the disease than previously thought.
The new vaccine is supposed to target a bacteria called Clostridium Bolteae, a distant cousin of bolutism and C. Diff.
Clostridium B. seems to be more prevalent in children who have autism. In fact autistic children have a whole range of intestinal symptoms including severe ones. 75% of those children who do have gastrointestinal complications, also have recurrent diahrroea.
Clostridium B. seems to be more prevalent in children who have autism. In fact autistic children have a whole range of intestinal symptoms including severe ones. 75% of those children who do have gastrointestinal complications, also have recurrent diahrroea.
Some researchers believe that some toxins produced by Clostridium Bolteae, just like all other forms of Clostridium, have a toxic effect on the organism, and in the case of autism, they believe that it makes their autistic symptoms worse, especially in regressive autism.
The introduction of the vaccine, will also make its detection easier, since the screening will be able to pick up vaccine-induced antibodies. All Clostridium bacteria is somewhat difficult to detect.
Source: Science Daily 4.25.13
No comments:
Post a Comment